114 related articles for article (PubMed ID: 33262538)
1. Circulating MicroRNA-30e Predicts Left Ventricular Hypertrophy In Essential Hypertensive Patients.
Xu H; Xu Y; Yang J; Juang J
Rev Invest Clin; 2020 Dec; ():. PubMed ID: 33262538
[TBL] [Abstract][Full Text] [Related]
2. Expression of soluble ST2 in patients with essential hypertension and its relationship with left ventricular hypertrophy.
Wei P; Liu L; Wang X; Zong B; Liu X; Zhang M; Fu Q; Wang L; Cao B
ESC Heart Fail; 2023 Feb; 10(1):303-310. PubMed ID: 36210061
[TBL] [Abstract][Full Text] [Related]
3. Serum MicroRNA-27b as a Screening Biomarker for Left Ventricular Hypertrophy.
Wang Y; Chen S; Gao Y; Zhang S
Tex Heart Inst J; 2017 Dec; 44(6):385-389. PubMed ID: 29276436
[TBL] [Abstract][Full Text] [Related]
4. [Association between plasma microRNA-29a and left ventricular hypertrophy in patients with hypertension].
Yao SY; Liu J; Li Y; Wang M; Wang C; Xue H
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Mar; 47(3):215-220. PubMed ID: 30897881
[No Abstract] [Full Text] [Related]
5. Correlations of circulating miR-26b level with left ventricular hypertrophy and cardiac function in elderly patients with hypertension.
Fu J; Lin F; Pan Z; Wu C
Pak J Med Sci; 2021; 37(4):966-971. PubMed ID: 34290767
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated microRNAs involved in contrast-induced acute kidney injury in rat and human.
Gutiérrez-Escolano A; Santacruz-Vázquez E; Gómez-Pérez F
Ren Fail; 2015; 37(9):1498-506. PubMed ID: 26337190
[TBL] [Abstract][Full Text] [Related]
7. Circulating miRNA29 family expression levels in patients with essential hypertension as potential markers for left ventricular hypertrophy.
Huang Y; Tang S; Huang C; Chen J; Li J; Cai A; Feng Y
Clin Exp Hypertens; 2017; 39(2):119-125. PubMed ID: 28287884
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of Tregs in hypertension-associated left ventricular hypertrophy.
Tang Y; Shen L; Bao JH; Xu DY
J Clin Hypertens (Greenwich); 2023 Jun; 25(6):562-572. PubMed ID: 37196041
[TBL] [Abstract][Full Text] [Related]
9. Identification and Confirmation of the miR-30 Family as a Potential Central Player in Tobacco-Related Head and Neck Squamous Cell Carcinoma.
Zhang T; Zhu X; Sun Q; Qin X; Zhang Z; Feng Y; Yan M; Chen W
Front Oncol; 2021; 11():616372. PubMed ID: 34336638
[TBL] [Abstract][Full Text] [Related]
10. The Expression of miR-365 in Serum of Hypertension Patients with Left Ventricular Hypertrophy Was Up-Regulated, Which Was Positively Correlated with Left Ventricular Mass Index.
Wu HB; Yang CS; Wang YC; Xie YT; Wang XC; Liu HL; Du RP
Pharmgenomics Pers Med; 2021; 14():905-913. PubMed ID: 34321907
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.
Lee H; Park CS; Deftereos G; Morihara J; Stern JE; Hawes SE; Swisher E; Kiviat NB; Feng Q
World J Surg Oncol; 2012 Aug; 10():174. PubMed ID: 22925189
[TBL] [Abstract][Full Text] [Related]
12. Circulating level of miR-378 predicts left ventricular hypertrophy in patients with aortic stenosis.
Chen Z; Li C; Xu Y; Li Y; Yang H; Rao L
PLoS One; 2014; 9(8):e105702. PubMed ID: 25157568
[TBL] [Abstract][Full Text] [Related]
13. Four-Dimensional Volume-Strain Expression in Asymptomatic Primary Hypertension Patients Presenting with Subclinical Left Atrium-Ventricle Dysfunction.
Ran H; Schneider M; Wan LL; Ren JY; Ma XW; Zhang PY
Cardiology; 2020; 145(9):578-588. PubMed ID: 32756051
[TBL] [Abstract][Full Text] [Related]
14. Relationship Between Circulating MicroRNAs and Left Ventricular Hypertrophy in Hypertensive Patients.
Lopes ECP; Paim LR; Carvalho-Romano LFRS; Marques ER; Minin EOZ; Vegian CFL; Pio-Magalhães JA; Velloso LA; Coelho-Filho OR; Sposito AC; Matos-Souza JR; Nadruz W; Schreiber R
Front Cardiovasc Med; 2022; 9():798954. PubMed ID: 35498018
[TBL] [Abstract][Full Text] [Related]
15. Relationship between circulating concentration of Ang II, ADM and ADT and left ventricular hypertrophy in hypertension.
Cui Y; Zhu Z; Qi X; Li H; Wu Y; Chen W; Liu Y
Am J Transl Res; 2019; 11(5):3167-3175. PubMed ID: 31217886
[TBL] [Abstract][Full Text] [Related]
16. Analysis of alterations of serum inflammatory cytokines and fibrosis makers in patients with essential hypertension and left ventricular hypertrophy and the risk factors.
Li X; Guo X; Chang Y; Zhang N; Sun Y
Am J Transl Res; 2022; 14(6):4097-4103. PubMed ID: 35836904
[TBL] [Abstract][Full Text] [Related]
17. [The prognostic value of circulating microRNA-29b in left ventricular hypertrophy in patients with hypertension].
Zhou XH; Cai JP; Liu WL; Zhang X; Wu XJ; Gao CY
Zhonghua Nei Ke Za Zhi; 2019 Apr; 58(4):278-281. PubMed ID: 30917420
[No Abstract] [Full Text] [Related]
18. Angiotensin-converting enzyme gene 2350 G/A polymorphism is associated with left ventricular hypertrophy but not essential hypertension.
Pan M; Zhu JH; Liu ZH; Jiang WP; Cui ZC; Yu XH; Li HM; Yang XJ
Hypertens Res; 2007 Jan; 30(1):31-7. PubMed ID: 17460369
[TBL] [Abstract][Full Text] [Related]
19. Erythrocyte ion fluxes in essential hypertensive patients with left ventricular hypertrophy.
de la Sierra A; Coca A; Paré JC; Sánchez M; Valls V; Urbano-Márquez A
Circulation; 1993 Oct; 88(4 Pt 1):1628-33. PubMed ID: 8403309
[TBL] [Abstract][Full Text] [Related]
20. A novel DSN-based fluorescence assay for MicroRNA-133a detection and its application for LVH diagnosis in maintenance hemodialysis patients.
Huang P; Guo X; Jin Y; Huang Q
J Clin Lab Anal; 2020 Oct; 34(10):e23438. PubMed ID: 32677047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
